To Get Help Now
Click Here
 
Today's Date:

Johnson & Johnson Unit Slapped with $2.5 Million Judgment Over Allegations That the Drug Risperdal Causes Breast Growth in Men

A Johnson & Johnson (J&J) unit has been slapped with a $2.5 million judgment over allegations that the company failed to warn the family of an autistic boy and his doctors about the risks of hormonal imbalances and breast growth associated with the drug Risperdal.

A Philadelphia County Court of Common Pleas jury slammed Janssen Pharmaceuticals with the decision on Tuesday after hearing evidence that J&J’s Janssen Pharmaceuticals unit had spent years trying to cover up data that showed Risperdal could cause breast growth in adolescent males, known as gynecomastia. Thousands of product liability lawsuits over the drug are pending across the country. Tuesday’s verdict is the first, according to Law360. More Johnson & Johnson Unit Slapped with $2.5 Million Judgment Over Allegations That the Drug Risperdal Causes Breast Growth in Men

Health Officials Learned of the Link Between Duodenoscopes and Superbugs in 2009

Defectively designed duodenoscopes may have exposed many as 179 patients to a “superbug” at UCLA’s Ronald Reagan Medical Center in Los Angeles, and U.S. health regulators have known about the problem since at least 2009.

Reuters reports that the U.S. Food and Drug Administration (FDA) has not recommended any new safety requirements, despite the fact that it knew as far back as 2009 that duodenoscopes can spread potentially deadly, multidrug-resistant superbugs. Last Thursday, the agency issued a “safety communication,” warning healthcare providers that the “complex design” of duodenoscopes could make them difficult to clean, but offered no further recommendations. For the first time, the FDA said that patients have still contracted deadly bacteria from the devices, even after hospitals strictly followed the manufacturer’s sterilization instructions. More Health Officials Learned of the Link Between Duodenoscopes and Superbugs in 2009

Millions of Americans may be Putting Themselves at Risk for Cancer by Daily Consuming Sodas

The caramel coloring in sodas like Coca-Cola and Pepsi may be putting consumers at risk for developing cancer, a new study has revealed.

According to researchers from Consumer Reports and the Center for a Livable Future at the Johns Hopkins Bloomberg School of Public Health, these sodas contain a potential carcinogen called 4-methylimidazole (4-MEI). The chemical is formed during the manufacture of caramel colorings in many sodas. A massive number of people are at risk: Between 44 and 59 percent of American adults report drinking at least one can of soda per day. The scientists published their findings in the journal PLOS ONE, according to Newsmax Health. More Millions of Americans may be Putting Themselves at Risk for Cancer by Daily Consuming Sodas

Nearly 800 Patients Possibly Exposed to Superbug at Large Los Angeles Hospital

800 Patients Exposed to Superbug at Los Angeles Hospital

800 Patients Exposed to Superbug at Los Angeles Hospital


Endoscopy procedures at the University of California, Los Angeles (UCLA) hospital may have exposed 179 patients to a multidrug-resistant superbug.

Seven endoscopy patients at the University of California, Los Angeles (UCLA), have been confirmed to have the carbapenem-resistant Enterobacteriaceae, or CRE, including two who died. The hospital warned 179 more patients that they may have been exposed to CRE and offered them home testing kits that would be analyzed by the hospital system, according to Reuters. More Nearly 800 Patients Possibly Exposed to Superbug at Large Los Angeles Hospital

MRI Systems Recalled Over Connection Issues

MRI Systems Recalled Over Connection Issues

MRI Systems Recalled Over Connection Issues

A Class I recall has been issued for almost 13,000 General Electric MRI systems due to a potentially life-threatening technical problem.

The recall affects more than 12,968 MRI systems and numerous brands, including Signa and Discovery. The recall includes 5,708 devices in the United States and 7,260 in other countries. The U.S. Food and Drug Administration (FDA) said in a February 18 Class I recall notice that “In emergency situations, a disconnected MRU could delay removal of a ferrous object from the magnet, potentially resulting in life-threatening injuries.” A Class I recall indicates that the affected device has the potential to cause serious injury or death. It is the FDA’s most serious recall designation. More MRI Systems Recalled Over Connection Issues

Former NYPD Officer to Receive Enhanced Disability Pension for Fibromyalgia Caused by Ground Zero Toxins

Former NYPD Officer to Receive Enhanced Disability Pension

Former NYPD Officer to Receive Enhanced Disability Pension

A retired New York Police Department (NYPD) officer who developed fibromyalgia and other health conditions after working at Ground Zero will receive an enhanced disability pension after a five-year legal battle. The Appellate Division in Manhattan overturned a lower court ruling which had found that her health problems were not caused by her exposure to toxic substances while working at the site of the fallen World Trade Center (WTC) towers.

Court documents show the police officer began to experience dizziness, shortness of breath, nausea and chest pains shortly after she started working at Ground Zero, where she was stationed at a security post for two months following the September 11, 2001 terror attacks. The New York Daily News reported that the former cop joined the NYPD in 1998. In 2002, the police officer was diagnosed with fibromyalgia, asthma, chronic fatigue syndrome and acid reflux, as well as toxic levels of heavy metals (cadmium, lead and mercury). More Former NYPD Officer to Receive Enhanced Disability Pension for Fibromyalgia Caused by Ground Zero Toxins

Design Defect in Duoendoscopes Makes Sterilization Difficult and May Spread Drug-Resistant Infections, FDA Warns

Design Defect in Duoendoscopes Makes Sterilization Difficult

Design Defect in Duoendoscopes Makes Sterilization Difficult


The U.S. Food and Drug Administration (FDA) issued a safety alert on Tuesday warning that  ERCP endoscopes, also known as duoendoscopes, may not be sterile because the complex design of the devices makes them difficult to process.

Duoendoscopes are flexible, lighted tubes that are threaded through the mouth, throat, stomach, and into the top of the small intestine (the duodenum). Contrast dye can be injected and other instruments can be inserted through a hollow chamber within the dueoendoscope to take tissue samples for biopsy or to treat certain anomalies. More Design Defect in Duoendoscopes Makes Sterilization Difficult and May Spread Drug-Resistant Infections, FDA Warns

Maine Department of Health and Human Services Settles Whistleblower Suit with Former Employee

Maine Dept of HHS Settles Suit with Former Employee

Maine Dept of HHS Settles Suit with Former Employee


A former employee of the Maine Department of Health and Human Services (DHHS) will receive $142,500 from the department to settle a federal whistleblower suit.

The former division director for the Maine Center for Disease Control (CDC) sued DHHS and her bosses at the CDC, alleging that she was harassed and retaliated against for refusing to shred public documents. The DHHS released the settlement agreement last Friday, according to the Sun Journal (SJ). More Maine Department of Health and Human Services Settles Whistleblower Suit with Former Employee

Federal Judge sets Yaz Birth Control Trial Date, Accuses Bayer of Trying to “Wear Everyone Down”

Judge sets Yaz Birth Control Trial Date

Judge sets Yaz Birth Control Trial Date


An Illinois federal judge overseeing the Yaz birth control multidistrict litigation (MDL) set a trial date on Friday for one of the suits in the litigation.

The MDL involves allegations that Bayer HealthCare Pharmaceuticals, Inc.’s Yaz birth control drug causes strokes. In an order viewed by Law360, U.S. District Judge David R. Herndon said that Bayer had failed to properly conduct analyses or negotiations in certain cases alleging the drugs cause blood clots. He said that he believed that Bayer’s strategy was one of “attrition,” and that it amounted to “wearing everyone down over time.” More Federal Judge sets Yaz Birth Control Trial Date, Accuses Bayer of Trying to “Wear Everyone Down”

Train Derails, Erupts into Fireball in West Virginia

Train Derails, Erupts into Fireball in West Virginia


Train Derails, Erupts into Fireball in West Virginia


A fireball erupted from a derailed CSX Corp train hauling North Dakota crude in West Virginia on Monday, lighting train cars on fire, destroying a house, and forcing the evacuation of two towns.

Initial reports claimed that at least one of the tank cars had fallen into the river, but CSX said Tuesday that that was not the case. Amazingly, no deaths were reported; however, one person was treated for potential fume inhalation. As of Tuesday, the train was still on fire and leaking oil, according to Reuters. More Train Derails, Erupts into Fireball in West Virginia